benign prostatic hyperplasia

(redirected from Benign prostatic hypertrophy)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
  • noun

Synonyms for benign prostatic hyperplasia

enlarged prostate

Synonyms

Related Words

References in periodicals archive ?
IVAX Corporation's (AMEX:IVX) Hungarian subsidiary, the IVAX Institute for Drug Research, has received approval to conduct a multi-center placebo-controlled human phase II study of its new molecule, GYKI-16084, in men with benign prostatic hypertrophy (BPH).
Synaptic Pharmaceutical Corporation (Paramus, NJ; 201-261-1331) announced the granting of non-exclusive licenses covering Synaptic's alpha-1 adrenergic receptors and benign prostatic hypertrophy patents to The R.
Because it is a normal accompaniment of aging in most men, it's called benign prostatic hypertrophy (BPH), and should give no cause for alarm unless urination becomes difficult, too frequent, urinary leakage occurs, or one is forced to remain at the public urinal while several other men come and go in the meantime.
The problem: a swollen prostate gland, or benign prostatic hypertrophy (BPH).
1]-antichymotrypsin-PSA (ACT-PSA) in patients with prostate carcinoma (PCa) but not in those with benign prostatic hypertrophy (BPH).
Propecia is the same medication as Proscar, which is used for benign prostatic hypertrophy at the five-milligram strength.
The procedure used to be a fixed cost: you were male, you aged, you started getting up 3 or 4 times a night to relieve yourself, and you and your doctor determined a TURP was a fixed cost of your benign prostatic hypertrophy diagnosis.
For example, a resident with a neurogenic bladder or benign prostatic hypertrophy, has an acceptable diagnosis for using a Foley.
Spectrum Pharmaceuticals (NasdaqGM: SPPI), a commercial-stage biotechnology company with a primary focus in oncology, today announced that it is discontinuing development of ozarelix in benign prostatic hypertrophy (BPH).
This type of enlargement is known as benign prostatic hypertrophy (BPH).
VA106483 is currently being investigated as a new treatment for nocturia in a 30-patient clinical trial to evaluate the dose-response in men aged over 65 years with benign prostatic hypertrophy (BPH).
Men who take both types of anticholinergics concomitantly and men who have benign prostatic hypertrophy (BPH) are at highest risk for developing acute urinary retention, which is considered a urologic emergency, said Dr.
High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy.
Benign Prostatic Hypertrophy (BPH), or enlargement of the prostate, is caused by an over-production of the growth-stimulating hormone DHT, which is found in testosterone.
Full browser ?